Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and Mission Bay Capital BioLabs ("MBC BioLabs"), a life-science incubator, today...
HistoSonics, (www.histosonics.com), the developer and manufacturer of a completely non-invasive platform and proprietary sonic beam therapy, announced the publication of results from their prospective...
Advanced NanoTherapies, Inc., a privately-held medical device company committed to solving vascular disease's most significant challenges through the creative applications of nanotechnology, today announced...
Abbott announced data from five late-breaking presentations showing the benefits of its minimally invasive devices in treating people with a range of structural heart...
Boston Scientific Corporation has announced results from the PROTECTED TAVR clinical trial evaluating the SENTINEL Cerebral Protection System, which is designed to capture and...
